Letermovir for the Prevention of Cytomegalovirus Infection Following Intensive Immunosuppressive Therapy (ChiCTR) - Apr 23, 2026 - P4 | N=110 | Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University); Jiangsu Province Hospital (The First Affiliated Hospital wi
New P4 trial • Anemia • Aplastic Anemia • Cytomegalovirus Infection • Hematological Disorders • Infectious Disease
|